In the Netherlands

The Netherlands is the cradle of market access development. From 1991 onwards, our firm has gone through all developmental steps from sole therapeutic evaluations to full health-economic models and price negotiations. This national experience has provided vast insight and vision into the evolutionary mechanisms and methodologies of assessment procedures.